Skip to main content
. Author manuscript; available in PMC: 2023 Apr 4.
Published in final edited form as: Autism Res. 2017 Jun 22;10(10):1672–1686. doi: 10.1002/aur.1817
N ASD N Other disorders Sensitivity 95% CI Specificity 95% CI LR+ LR−
TP FN TN FP
Total
 ADOS 59 6 226 48 91%, 81–97 83%, 78–87 5 0.11
 ADI-research (res) 30 35 262 12 46%, 34–59 96%, 93–98 11 0.56
 ADI-clinical (clin) 44 21 247 27 68%, 55–79 90%, 86–93 7 0.36
 ADI-clin & ADOS 39 26 265 9 60%, 47–72 97%, 94–99 18 0.41
 ADI-clin or ADOS 64 1 208 66 99%, 92–100 76%, 70–81 4 0.02
Phrase-speech (PS)
 ADOS 31 3 176 28 91%, 76–98 86%, 81–91 7 0.10
 ADI-res 11 23 198 6 32%, 17–51 97%, 94–99 11 0.70
 ADI-clin 20 14 190 14 59%, 41–75 93%, 89–96 9 0.44
 ADI-clin & ADOS 17 17 198 6 50%, 32–68 97%, 94–99 17 0.52
 ADI-clin or ADOS 34 0 168 36 100%, 90–100 82%, 76–87 6 <0.01
Single words (SW)
 ADOS 17 3 40 16 85%, 62–97 71%, 58–83 3 0.21
 ADI-res 11 9 51 5 55%, 32–77 91%, 80–97 6 0.49
 ADI-clin 16 4 44 12 80%, 56–94 79%, 66–88 4 0.25
 ADI-clin & ADOS 14 6 53 3 70%, 46–88 95%, 85–99 13 0.32
 ADI-clin or ADOS 19 1 31 25 95%, 75–100 55%, 42–69 2 0.09
Nonverbal (NV)
 ADOS 11 0 10 4 100%, 72–100 71%, 42–92 4 <0.01
 ADI-res 8 3 13 1 73%, 39–94 93%, 66–100 10 0.29
 ADI-clin 8 3 13 1 73%, 39–94 93%, 66–100 10 0.29
 ADI-clin & ADOS 8 3 14 0 73%, 39–94 100%, 77–100 na 0.27
 ADI-clin or ADOS 11 0 9 5 100%, 72–100 64%, 35–87 3 <0.01

ADI, autism diagnostic interview-revised; ADOS, autism diagnostic observation schedule; ASD, autism spectrum disorder; LR+, positive likelihood ratio; LR−, negative likelihood ratio. TP=true positives, TN=true negatives, FP, false positives; FN, false negatives; CI, confidence interval.

ADI-research cutoffs: NV = 13, SW = 13, PS = 16. ADI-clinical cutoffs: NV = 11, SW = 8, PS = 13. ADOS-2 ASD cutoff: Module 1-no words = 11, Module 1-some words=8, Module 2-phrase-speech = 7.